Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Estrategias analíticas integradas para potenciar la sensibilidad de los inmunoensayos de flujo lateral en entornos de punto de atención clínica

  • Banguera Ordóñez, Yulieth Deifan
[ES] Actualmente existe un creciente interés por desarrollar sistemas bioanalíticos robustos, sostenibles y capaces de proporcionar información molecular confiable en tiempos reducidos. Una vía eficaz para lograrlo es el diseño de dispositivos altamente integrados que permitan realizar pruebas Point-of-Care (PoC), es decir, analisis efectuados en el mismo lugar y momento de la toma de muestra. Estos dispositivos son esenciales tanto en entornos que requieren resultados inmediatos, como urgencias u atención primaria, como en contextos donde el usuario no especializado debe ejecutar la prueba, incluidos hogares o lugares de trabajo. Ejemplos emblemáticos de estos ensayos son la prueba de embarazo y los test rápidos de COVID-19. Para satisfacer las necesidades actuales, los ensayos PoC deben ser económicos, sencillos, selectivos y sensibles, ofrecer resultados rápidos y fiables, y no depender de equipamiento adicional. En este marco, el inmunoensayo en flujo lateral (LFIA) ha demostrado ser una herramienta versátil durante más de siete décadas en campos clínicos, alimentarios y medioambientales. Su éxito radica en su excelente relación coste-efectividad, al estar fabricado con materiales basados en papel, y en su arquitectura simple, que permite el flujo capilar en un solo paso. Sin embargo, su principal ventaja, el corto tiempo de reacción, también constituye una limitación: la interacción antígeno-anticuerpo es breve, lo que disminuye la sensibilidad analítica en comparación con técnicas como ELISA, cuyos tiempos de incubación son mucho más largos. Esto restringe la aplicabilidad del LFIA en el ámbito clínico, donde muchos biomarcadores relevantes se encuentran en niveles pico-femtomolares y pueden estar enmascarados por proteínas plasmáticas mucho más abundantes. Por ello, la investigación reciente se ha centrado en estrategias para mejorar la sensibilidad del LFIA mediante pretratamiento de muestras, amplificación de señal o aumento del tiempo de interacción. En este contexto se sitúan los tres desarrollos presentados en esta tesis, organizados en capítulos equivalentes a tres publicaciones científicas. El primer trabajo propone una estrategia simple y económica basada en nanopartículas de carbono como transductores colorimétricos. Estas nanopartículas generan un color negro con una relación señal-ruido muy superior a la de las nanopartículas de oro, permitiendo mejorar 55 veces el límite de cuantificación y alcanzar 1.5 ng/mL en la detección de lactato deshidrogenasa (LDH) en suero humano. El segundo estudio emplea nanopartículas de europio Bright-Dtech-614 como etiquetas fluorescentes de tiempo resuelto. Gracias a su rendimiento cuántico del 70 % y una eficiencia de conjugación del 90%, logrando un límite de detección de 38 pg/mL, mejorando la sensibilidad en 686, 15 y 2.9 veces respecto a LFIA con oro, carbono y ELISA, respectivamente. El tercer trabajo presenta un sistema innovador basado en la modulación del flujo mediante electroforesis, usando un dispositivo portátil impreso en 3D que permite etapas controladas de incubación y lavado directamente en la tira. Este formato alcanzó un límite de detección de 70 pg/mL para h-LDH utilizando nanopartículas de oro, lo que supone una mejora de sensibilidad de 367 veces frente al LFIA convencional. En conjunto, estas tres estrategias demuestran un gran potencial para impulsar la medicina de precisión en el punto de atención, permitiendo la cuantificación de biomarcadores clínicamente relevantes de forma rápida, económica y adaptable mediante el uso de distintos elementos de bioreconocimiento, [CA] Actualment existeix un interès creixent pel desenvolupament de sistemes bioanalítics robusts i sostenibles capaços de proporcionar informació molecular precisa en temps reduïts. Una estratègia adequada per donar resposta a aquesta necessitat és la implementació de sistemes altament integrats que permeten solucions Point-of-Care (PoC), definides com proves diagnòstiques realitzades en el mateix lloc i moment de la presa de mostra. Aquest tipus d'assajos és especialment rellevant en entorns que requereixen resultats immediats, com les unitats d'emergència o les consultes d'atenció primària, així com en espais on les proves poden ser efectuades per personal no especialitzat, com domicilis o llocs de treball. Entre els exemples més exitosos d'assajos PoC en format de tira reactiva es troben la prova d'embaràs i els glucòmetres. Per aquest motiu, en els darrers anys la recerca s'ha orientat cap a estratègies que milloren la sensibilitat del LFIA mitjançant pretractament de mostra, amplificació de senyal o modulació del temps d'interacció antigen-anticòs. En aquest marc s'emmarquen els objectius de la present tesi, estructurada en tres capítols que corresponen a tres publicacions científiques. El primer capítol presenta una estratègia econòmica i senzilla basada en l'ús de nanopartícules de carboni com a transductors colorimètrics. Aquestes nanopartícules proporcionen una relació senyal-soroll notablement superior a la de les nanopartícules d'or, millorant 55 vegades el límit de quantificació i assolint 1,5 ng/mL en la detecció de lactat deshidrogenasa (LDH) en sèrum humà. El segon capítol descriu una estratègia basada en nanopartícules d'europi com a transductors fluorescents. Les Bright-Dtech-614, amb un rendiment quàntic del 70% i un 90% d'eficiència de conjugació, permeten un límit de detecció de 38 pg/mL per a LDH, amb millores de sensibilitat de 686, 15 i 2,9 vegades respecte a plataformes basades en nanopartícules d'or, nanopartícules de carboni i ELISA estàndard. El tercer capítol presenta un dispositiu electroforètic portàtil imprés en 3D, capaç de realitzar etapes iteratives d'incubació i rentat directament sobre la tira de nitrocel·lulosa. Amb nanopartícules d'or com a transductors, aquesta plataforma aconsegueix un límit de detecció de 70 pg/mL per a LDH humana, equivalent a una millora de 367 vegades davant del LFIA convencional. En conjunt, les tres estratègies desenvolupades en aquesta tesi mostren un alt potencial per avançar en la medicina de precisió al punt d'atenció, permetent la quantificació ràpida, sensible i econòmica de biomarcadors clínicament rellevants, amb una versatilitat que facilita la seua adaptació a múltiples aplicacions mitjançant el simple reemplaçament dels elements de bioreconeixement., [EN] There is increasing interest in developing robust and sustainable bioanalytical systems capable of providing high-quality molecular information in short timeframes. A promising strategy involves highly integrated diagnostic platforms that enable Point-of-Care (PoC) testing, defined as diagnostic assays performed directly at the time and place of sample collection. These tests are essential in settings requiring rapid results, such as emergency units or primary care clinics, and in contexts where analyses must be performed by non-specialized users, including workplaces or home environments. Classic examples of PoC tests based on lateral flow formats are pregnancy tests and COVID-19 rapid assays. To meet current diagnostic demands, PoC tests must be cost-effective, simple to operate, analytically reliable, and capable of delivering sensitive and selective results without the need for external instrumentation. Within this framework, the lateral flow immunoassay (LFIA) has demonstrated remarkable versatility over the past 70 years across fields such as clinical diagnostics, food safety, and environmental monitoring. More recently, LFIA technologies were critical during the COVID-19 pandemic for both serological screening and antigen detection. Their success is largely attributable to their low-cost, paper-based design and straightforward architecture, which relies on capillary flow through overlapping pads on a support. This one-step format is highly advantageous; however, the very short assay time (10-15 minutes) significantly limits the duration of antigen-antibody interactions, ultimately reducing analytical sensitivity in comparison to ELISA assays with longer incubation times. This constraint hinders LFIA applicability in the detection of clinically relevant biomarkers present at pico- to femtomolar concentrations, often masked by abundant plasma proteins. For this reason, recent research efforts have focused on improving LFIA sensitivity through sample pretreatment, signal amplification, or modulation of antigen-antibody interaction dynamics. This thesis addresses these challenges through three complementary strategies, each presented as a scientific publication. Chapter 1 introduces a cost-effective approach using carbon nanoparticles (CNPs) as colorimetric signal transducers. CNPs generate a deep-black signal that provides a significantly higher signal-to-noise ratio than gold nanoparticles (AuNPs), improving the limit of quantification 55-fold and achieving 1.5 ng/mL for lactate dehydrogenase (LDH) detection in human serum. Chapter 2 explores the use of europium nanoparticles (EuNPs) as fluorescent time-resolved reporters. Bright-Dtech-614 EuNPs exhibit a 70% luminescence quantum yield and 90% antibody-conjugation efficiency, enabling an LDH detection limit of 38 pg/mL. This corresponds to improvements of 686-fold over AuNP-LFIA, 15-fold over CNP-LFIA, and 2.9-fold over standard ELISA. Chapter 3 presents a novel strategy based on electrophoretic flow modulation. A lightweight (151 g), 3D-printed electrophoretic device was developed, capable of performing iterative incubation and washing steps directly on the LFIA strip¿an impossibility for traditional capillary-driven systems. Using AuNPs as reporters, this platform achieved a detection limit of 70 pg/mL for human LDH, representing a 367-fold improvement compared to conventional LFIA. Collectively, these three approaches demonstrate substantial potential to advance precision medicine at the point of care by enabling the rapid, cost-effective, and highly sensitive quantification of clinically relevant biomarkers. Moreover, their versatility allows adaptation to a wide range of targets through the substitution of biorecognition elements., Y.D.B.O. acknowledges the financial support of the Ministerio de Ciencia Tecnología e Innovación Scholarship Program No. 8852 of Colombia. A.S. acknowledges Generalitat Valenciana and the European Social Fund for the CIAPOS fellowship (CIAPOS/2022/7). S.M. awards grant PID2019-110713RB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by "ERDF A way of making Europe”
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Smartphone-based lateral flow immunoassay for sensitive determination of Lactate Dehydrogenase at the point of care

  • Banguera-Ordoñez, Yulieth Deifan
  • Quintero-Campos, Pedro|||0000-0002-9398-5077
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
  • Sena-Torralba, Amadeo
[EN] Lactate dehydrogenase (LDH), a prevalent enzyme involved in anaerobic glycolysis, is released into body fluids following cell damage and has long been a general marker of tissue injury. However, due to its lack of selectivity and the advent of more accurate biomarkers, the clinical utility of LDH has been largely limited to confirming hemolysis. LDH has been recognized as a valuable prognostic biomarker for various cancers, making its monitoring crucial during cancer management. Traditional LDH methods include spectrophotometric analysis of NADH at 340 nm, native electrophoresis, or enzyme-linked immunosorbent assay. This study presents the first lateral flow immunoassay (LFIA) for the smartphone-based quantification of serum LDH levels at the point of care. Highly-affinity and specific antibodies have been produced, with 5 nM equilibrium dissociation constant and no cross-reactivity with human serum albumin and human immunoglobulin G. Utilizing carbon nanoparticles as signal transducers significantly enhanced the quantification limit 55-fold, compared to the conventional gold nanoparticles-based LFIA, achieving a quantification limit of 1.5 ng mL¿ 1 . The developed assay demonstrated a mean recovery rate of 115 ± 21 % when evaluating LDH-spiked serum samples. This method can be an interesting home-testing tool for monitoring cancer progression or therapy effectiveness., Y.D.B.O. acknowledges the financial support of the Ministerio de Ciencia Tecnología e Innovacion Scholarship Program No. 8852 of Colombia. A.S. acknowledges Generalitat Valenciana and the European Social Fund for the CIAPOS fellowship (CIAPOS/2022/7). S.M. awards grant PID2019-110713RB-I00 funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Advancing Chemical Education in Biotechnology Undergraduates: A Hands-On Laboratory Experiment to Teach the Lateral Flow Immunoassay for Biomarker Detection

  • Banguera-Ordoñez, Yulieth Deifan
  • Sena-Torralba, Amadeo
  • Hernanz-Grimalt, Ana
  • Martorell-Tejedor, Sara
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
[EN] The lateral flow immunoassay (LFIA) is a simple and cost-effective rapid diagnostic test designed for the on-site detection of disease biomarkers. In the context of introducing this technique to undergraduate biotechnology students, we propose a comprehensive 5 h laboratory experiment. This experiment covers various aspects, including the bioconjugation of gold nanoparticles with antibodies, optimization of the bioconjugation procedure using the gold aggregation test, lab-scale manufacturing of the test strips, and the detection of the human protein biomarker lactate dehydrogenase as a proof of concept. Several strategies are employed to assess student learning in the context of this laboratory experiment. These strategies include pre-lab and post-lab discussions, a rubric for practical skills, observation and feedback, and a post-lab assessment requiring students to answer three in-depth questions on the material, procedure, and fundamentals covered, concluding with an end-of-lab report. The main goal of this experiment is to highlight the pedagogical potential inherent in utilizing cost-effective and accessible laboratory tools, specifically lateral flow immunoassays. The aim of integrating these methodologies is to provide students with a concrete and experiential understanding of analytical chemistry, biosensing, and nanotechnology, which are continually evolving fields., Y.D.B.-O. acknowledges the financial support of Ministerio de Ciencia Tecnologia e Innovacion Scholarship Program 8852 of Colombia. A.S.-T. acknowledges Generalitat Valenciana and the European Social Fund for the CIAPOS fellowship (CIAPOS/2022/7). S.M.-T. acknowledges the Margarita Salas fellowship funded by the European Union's Next Generation EU framework program. A.H.-G. acknowledges ayudas programa investigo, Plan de Recuperacion, Transformacion, y Resiliencia funded by the European Union - Next Generation EU.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

DNA-binding activity of PIF7 links phytochrome B signaling to plant responses to vegetation proximity

  • Diaz-Lopez, Marta
  • Pastor-Andreu, Pedro
  • Qin, Wenting
  • Sánchez-García, Ángela
  • Burbano-Erazo, Esteban
  • Valverde, Laura
  • Paulisic, Sandi
  • Rodriguez-Concepcion, Manuel
  • Moreno-Romero, Jordi
  • Martínez-García, Jaume F.
[EN] PHYTOCHROME INTERACTING FACTORs (PIFs) are transcription factors that act as central signaling hubs in light-regulated processes. All PIFs contain an active phytochrome B-binding motif and a DNA-binding basic helix-loop-helix domain. In the shade-avoider Arabidopsis thaliana, PIF7 is a major promoter of hypocotyl elongation in response to vegetation proximity, becoming active when released from phytochrome B via its active phytochrome B-binding motif. Here we show that PIF7 promotes seedling elongation in other species, including the shade-avoider tomato and the shade-tolerant Cardamine hirsuta, suggesting that PIF7 has retained some of its key functional domains across diverse plants. Through complementation analyses using PIF7 variants lacking either the active phytochrome B-binding or basic helix-loop-helix domain, we demonstrate that, unlike PIF3, PIF7 versions unable to bind phytochrome B remain active regardless of light conditions, whereas loss of DNA-binding capacity fully disrupts PIF7 function. Our results further suggest that phytochrome B interaction imposes a dual regulatory control over PIF7, modulating both its abundance and its phosphorylation state (ie its ability to bind and regulate target genes)., Support for this work was provided by a Juan de la Cierva postdoctoral contract (reference FJC2021-046591-I) to M.D.-L. funded by the AEI (Spanish Agencia Estatal de Investigacion, MCIU/AEI/10.13039/501100011033) and European extGenerationEU/PRTR, a postdoctoral contract funded by the European Commission (H2020-MSCA-IF-2017, Proposal 797473) and a Ramon y Cajal contract (RYC2020-028933-I) funded by the AEI and "ESF Investing in Your Future" to J.M.-R., a predoctoral Chinese Scholarship Council (CSC) fellowship to W.Q. (201806910055), and a predoctoral fellowship from Colombia's Colciencias Doctorado Exterior program (MINCIENCIAS885/2020) to E.B.-E. Our research is supported by the PRIMA project UToPIQ (PCI2021-121941) funded by the AEI and "European Union NextGeneration EU/PRTR" to M.R.-C.; grants BIO2017-85316-R (funded by the AEI and "ERDF A Way of Making Europe"), PID2020-115782GB-I00 (funded by the AEI), PLEC2022-009323 (funded by the AEI and "European Union NextGeneration EU/PRTR"), PID2023-149395NB-I00 (funded by the AEI and "ERDF/EU"), and CIPROM/2024/41 (funded by Generalitat Valenciana) to J.F.M.-G.; and PID2021-128803NB-I00 (funded by the AEI and "ERDF/EU") to J.M.-R. We are part of the Spanish network EvoDevoSigNet, RED2022-134917-T, funded by the AEI. This work was supported by institutional grant CEX2025-001626-S (Center of Excellence Severo Ochoa) funded by MCIU/AEI/10.13039/501100011033.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Breaking the picomolar barrier in lateral flow assays using Bright-Dtech 614-Europium nanoparticles for enhanced sensitivity

  • Lajoux, Juliette
  • Sena-Torralba, Amadeo
  • Charbonnière, Loïc J.
  • Sy, Mohamadou
  • Goetz, Joan
  • Banguera-Ordoñez, Yulieth Deifan
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
[EN] Lateral flow immunoassays (LFIA) are among the most widely used rapid diagnostic tests for point-of-care screening of disease biomarkers. However, their limited sensitivity hinders their use in complex clinical applications that require accurate biomarker quantification for precise medicine. To address this limitation, we evaluated Bright-Dtech¿-614 Europium nanoparticles to enhance LFIA assay sensitivity. These nanoparticles exhibited a luminescence quantum yield of 70¿% and a 90¿% conjugation efficacy with antibodies by direct adsorption. Considering these properties, we developed an LFIA to quantify human lactate dehydrogenase (h-LDH), a biomarker and therapeutic target in cancer disease. The Bright-Dtech¿-614 Eu nanoparticle-based assay achieved a detection limit of 38¿pg¿mL¿1, representing a 686-fold, 15-fold, and 2.9-fold improvement in sensitivity over conventional LFIA platforms using gold (AuNPs), carbon nanoparticles, and standard ELISA, respectively. The assay exhibited strong accuracy, with a mean recovery rate of 108¿±¿11¿%, and demonstrated excellent reproducibility, as evidenced by inter- and intra-batch RSD values of 4.9¿% and 9.7¿%, respectively, when testing LDH-spiked serum samples. By substituting traditional gold nanoparticles with the Bright-Dtech¿-614 Eu nanoparticles, we achieved detection limits in the femtomolar range, significantly broadening the applicability of LFIA for precision medicine., Y.D.B.O. acknowledges the financial support of the Ministerio de Ciencia Tecnología e Innovacion Scholarship Program No. 8852 of Colombia. A.S. acknowledges Generalitat Valenciana and the European Social Fund for the CIAPOS fellowship (CIAPOS/2022/7).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo de revisión (ReviewArticle)

Beyond Deterministic Forecasts: A Scoping Review of Probabilistic Uncertainty Quantification in Short-to-Seasonal Hydrological Prediction

  • De León Pérez, David|||0000-0002-1846-9750
  • Francés, F.|||0000-0003-1173-4969
  • Salazar-Galán, Sergio
[EN] This Scoping Review methodically synthesizes methodological trends in predictive uncertainty (PU) quantification for short-to-seasonal hydrological modeling-based forecasting. The analysis encompasses 572 studies from 2017 to 2024, with the objective of addressing the central question: What are the emerging trends, best practices, and gaps in this field? In accordance with the six-stage protocol that is aligned with PRISMA-ScR standards, 92 studies were selected for in-depth evaluation. The results of the study indicate the presence of three predominant patterns: (1) exponential growth in the applications of machine learning and artificial intelligence; (2) geographic concentration in Chinese, North American, and European watersheds; and (3) persistent operational barriers, particularly in data-scarce tropical regions with limited flood and streamflow forecasting validation. Hybrid statistical-AI modeling frameworks have been shown to enhance forecast accuracy and PU quantification; however, these frameworks are encumbered by constraints in computational demands and interpretability, with inadequate validation for extreme events highlighting critical gaps. The review emphasizes standardized metrics, broader validation, and adaptive postprocessing to enhance applicability, advocating robust frameworks integrating meteorological input to hydrological output postprocessing for minimizing uncertainty chains and supporting water management. This study provides an updated field mapping, identifies knowledge gaps, and prioritizes research for the operational integration of advanced PU quantification., This study was funded by the Colombian Ministry of Science, Technology, and Innovation (MINCIENCIAS) through the Call for Doctorates Abroad 885-2 (D.D.L.P.); by the Valencian Regional Government through the WATER4CAST 2.0 (CIPROM/2023/5) research project (D.D.L.P. and F.F.); Spanish Ministry of Science and Innovation through TETISPREDICT (PID2022-141631OB-I00) research project (D.D.L.P. and F.F.); and S.S.G. by research talent recruitment programme EMERGIA , Call 2021, Consejería de Universidad, Investigación e Innovación, Junta de Andalucía, Spain (EMC21_00413). The APC was funded by the Universitat Politècnica de València for open access through the aid program of the Vice-Rectorate for Research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Specific sets of geranylgeranyl diphosphate synthases and phytoene synthases control the production of carotenoids and ABA in different tomato tissues

  • Burbano-Erazo, Esteban
  • Ezquerro-Urzanqui, Miguel
  • Sánchez-Bel, Paloma
  • RODRIGUEZ-CONCEPCION, Manuel|||0000-0002-1280-2305
[EN] Plant carotenoids are plastid-synthesized isoprenoids with roles as photoprotectants, pigments, and precursors of bioactive molecules such as the hormone abscisic acid (ABA). The first step of the carotenoid biosynthesis pathway is the production of phytoene from geranylgeranyl diphosphate (GGPP), catalyzed by phytoene synthase (PSY). GGPP produced by plastidial GGPP synthases (GGPPS) is channeled to the carotenoid pathway by direct interaction of GGPPS and PSY enzymes. Three plastid-localized GGPPS isoforms (referred to as SlG1-3) and three PSY enzymes (PSY1-3) are present in tomato (Solanum lycopersicum). Our previous work showed that SlG1 and PSY3 function together in the roots, whereas the rest of the isoforms are required in aerial tissues. Here we generated and analyzed combinations of double mutants lacking PSY1 or PSY2 and SlG2 or SlG3 to investigate the contribution of specific GGPPS and PSY pairs to the production of carotenoids and ABA in different tissues of the tomato plant. Despite that the loss of individual enzymes was found to trigger compensatory mechanisms that complicate interpretation of the results, the results confirm a major role for SlG3 in providing GGPP to PSY2 for housekeeping carotenoid biosynthesis in leaves, whereas SlG2 and PSY1 become most relevant when a more active production is required in flowers and breaker fruits, i.e., at the onset of ripening. We could also confirm that ABA production in the fruit pericarp is more dependent on PSY1 activity than on total carotenoid levels and that fruit size correlates with ABA levels accumulated in ripe rather than breaker fruits., Agencia Estatal de Investigación, Grant/Award Numbers: BES-2017-080652, PCI2021-121941, PID2020115810GB-I00, PID2023-149584NB-I00, RED2022-134577-T; Generalitat Valenciana, Grant/Award Numbers: AGROALNEXT/2022/067, PROMETEU/2021/056; Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS), Grant/Award Number: MINCIENCIAS885/2020
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Development of a single-step lateral flow immunoassay for penicillin G allergy screening

  • Quintero-Campos, Pedro|||0000-0002-9398-5077
  • Banguera-Ordoñez, Yulieth Deifan
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
  • Sena-Torralba, Amadeo
[EN] Penicillin, a widely used narrow-spectrum antibiotic, remains the most frequently reported drug allergy. However, less than 20% of individuals reporting a penicillin allergy are truly allergic. Antibiotic allergy de-labeling is, therefore, essential to prevent adverse reactions and inappropriate treatments. We present the first single-step Lateral Flow Immunoassay for penicillin G allergy screening, offering real-time visual results at the point of care. The detection limit of 0.3 IU/mL of the assay, equivalent to 0.72 µg/L, determined in artificial human serum, enables the identification of class 0 allergy patients (<0.35 IU/ mL) per the RAST scale, distinguishing between low, medium, and high allergy severity groups with a smartphone reader over a dynamic range of 0.3¿10 IU/mL. This lateral flow assay for penicillin allergy screening enables a shift in allergy diagnostics from centralized laboratories to more accessible point-of-care settings, including doctors¿ offices and self-testing., Y. D. B. O. acknowledges the financial support of the Ministerio de Ciencia Tecnología e Innovación Scholarship Program No. 8852 of Colombia. A. S. acknowledges Generalitat Valenciana and the European Social Fund for the CIAPOS fellowship (CIAPOS/2022/7).